Using UT Southwestern's Cryo-Electron Microscopy Facility, researchers for the first time have captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological ...
Cell & Microbiology
Jul 11, 2022
0
41
The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and other diseases, according ...
Biochemistry
Jun 30, 2022
0
43
Despite its functionality, plastic could be posing a threat not only to the environment but to human health.
Environment
Jun 28, 2022
1
11
Researchers at Karolinska Institutet and SciLifeLab in Sweden describe in a study published in Science how they have improved the ability of a protein to repair oxidative DNA damage and created a new protein function. Their ...
Biochemistry
Jun 23, 2022
0
61
Friend or foe? Immune systems constantly face this question. They must recognize and clear foreign invaders without eliciting autoimmunity. Prokaryotic CRISPR-Cas systems recognize invaders based on genetic sequence. But ...
Cell & Microbiology
Jun 13, 2022
0
74
Proteins are like machines. For some diseases, it can be useful to turn these machine off or on when they are too active or not active enough. One way to control switching in a protein, such as a nuclear receptor, is to put ...
Molecular & Computational biology
Jun 1, 2022
0
5
Cyclic GMP-AMP synthase (cGAS), a double-stranded DNA (dsDNA) sensing protein, plays an important role in the strong innate immune response induced by pathogen derived nucleic acids.
Molecular & Computational biology
May 12, 2022
0
12
The breakthrough came on molecular biologist Christopher Garcia's birthday.
Molecular & Computational biology
Mar 10, 2022
1
836
QUT Ph.D. researcher Lauren Ashwood has studied sea anemones' venom makeup extensively, in particular, Telmatactis stephensoni a reef-based sea anemone that can grow from 8 to 10 cm.
Ecology
Feb 4, 2022
0
1007
Immunologists at St. Jude Children's Research Hospital have identified biochemical "switches" that control development of regulatory T cells and offer a novel strategy for treatment of autoimmune diseases and cancer. The ...
Cell & Microbiology
Dec 29, 2021
0
287
